anand deshpande : Latest News, Videos and Photos | Outlook Business
Home » Search
Search Result : "anand deshpande"

A substantial portion of the Persistent Systems' chairman's wealth will go to the DeAsra foundation

Pan India Paryatan's CEO Shirish Deshpande talks about his love for cricket

The Mahindra & Mahindra chairman is a self-effacing tycoon who lets his A-team have the final say

Even as Persistent Systems hits a 52-week low following a weak September quarter and exposure to IL&FS, promoter Anand Deshpande hikes his stake 

A favourite of Indian legends, Sanspareils Greenlands (SG) cricket kits are favoured globally

Harvard Business School professor Bharat Anand on using the internet to foster customer interaction

Jarsh Innovations' air-conditioned helmets make life easier for industrial workers

Visit’s AI-driven chatbot is looking to change the way patients consult doctors

Electric vehicles are in for a bumpy ride as automakers hesitate to take the big leap

Munjal-Burman’s winning bid for the beleaguered hospital chain raises more questions than answers

Ambi Parameswaran lists ways media companies can define their digital blueprint based on Bharat Anand’s analysis in ‘The Content Trap

ITC’s executive director Nakul Anand has sold stock worth Rs.64 crore in 2017 so far

Hockey has taught Nippon Paint India president, Mahesh Anand, how to think on his feet

Sticking to quality companies across cycles has helped Anand Radhakrishnan stay the course

Nilesh Shetty and Anand Shah on whether pharma stocks can make a comeback

About 200 rare books on Indian art recently changed hands at an online auction

Consensus earnings growth estimates for FY16 have already come down to just 7% 

Anand Agarwal, CEO, Sterlite Technologies, on five ways to boost morale

The founder of Sphereorigins on having watched Anand countless times

Honey Hut plans to bring a new twist to the concept of cafe chains 

Pan India Paryatan's CEO Shirish Deshpande is living his life on a high

The PE investors' bet is a mix of proprietary insights and ambitious assumptions

With a diverse therapy mix in the domestic market, it is now targeting exports to meet its ₹1,000-cr topline target

On Stands Now